Status:
WITHDRAWN
Comparison of OpeN VErsus RoboTic Partial Nephrectomy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Renal Masses
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A prospective randomized controlled feasibility trial for patients undergoing partial nephrectomy for T1 renal masses at Princess Margaret. Participants will be randomized receive either open or robot...
Detailed Description
This is an interventional, unblinded RCT where a total of 30 patients who have consented to undergo partial nephrectomy for a T1 renal mass under the care of a uro-oncologist at Princess Margaret Canc...
Eligibility Criteria
Inclusion
- Radiologically characterized T1 renal mass
- Elected for partial nephrectomy surgery
- Under the care of a uro-oncologist at Princess Margaret Cancer Centre
- Willing to comply with follow-up protocol
- Capable of providing informed consent
Exclusion
- Radiologically characterized tumours ≥ T1
- Unfit for general anesthetic
- Unsuitable for robotic surgery (determined by treating physician)
- Unwilling to comply with standardized follow-up protocol
- Evidence of metastatic disease
- Solitary kidney
- Previous surgery on affected kidney
- Multiple tumours
- Known genetic syndromes predisposing to multiple renal tumours (e.g., VHL, TS, BHD)
- Pregnancy
- Inability to read, understand, and complete the questionnaires written in English
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 24 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04011891
Start Date
November 1 2019
End Date
July 24 2023
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9